Compare VIDA & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIDA | CLNN |
|---|---|---|
| Founded | 2022 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 57.6M |
| IPO Year | 2026 | 2021 |
| Metric | VIDA | CLNN |
|---|---|---|
| Price | $0.73 | $3.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.20 |
| AVG Volume (30 Days) | 49.7K | ★ 93.0K |
| Earning Date | 11-16-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $200,000.00 |
| Revenue This Year | N/A | $25.30 |
| Revenue Next Year | N/A | $9,184.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.70 | $3.02 |
| 52 Week High | $4.25 | $10.84 |
| Indicator | VIDA | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 24.89 | 47.88 |
| Support Level | N/A | $3.78 |
| Resistance Level | $1.19 | $4.05 |
| Average True Range (ATR) | 0.13 | 0.38 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 6.27 | 19.34 |
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.